|
|
 |
CRMD004 is a novel gel formulation in pre-clinical development. This gel is “thixotropic” i.e. it changes from a semi-solid to a free flowing liquid under the pressure of insertion (or withdrawal from) a catheter. CRMD004 could be combined with taurolidine, other antimicrobials, anticoagulants or enzymes for use as a catheter lock.
We have worldwide rights to develop, manufacture and market CRMD004. |